Results of Institutional Entitlement Offer
Filed with ASX · · 1 page · English
Earlier from Somnomed
- Chairmans Letter
- Continuing High Growth in the Third Quarter
- SomnoMed continues to break records in 4th Quarter
- SomnoMed Accelerates Growth beyond Forecasts
- SomnoMed reports solid growth and stronger profits
Later from Somnomed
- Derek Smith appointed Global CEO of SomnoMed
- Strong finish to the financial year for SomnoMed
- FDA 510k approval for SomnoDent Alpha
- Sales growth accelerating
- Renew Sleep Solutions opens first two centres in Q2
Follow Somnomed into a list and get an email when it puts out news.
Follow Somnomed